138 related articles for article (PubMed ID: 11829024)
1. Space motion sickness medications: interference with biomedical parameters.
Vernikos-Danellis J; Winget CM; Leach CS; Rosenblatt LS; Lyman J; Beljan JR
Acta Astronaut; 1977; 4(11-12):1159-69. PubMed ID: 11829024
[TBL] [Abstract][Full Text] [Related]
2. Individual differences in susceptibility to motion sickness among six Skylab astronauts.
Graybiel A; Miller EF; Homick JL
Acta Astronaut; 1975; 2(1-2):155-74. PubMed ID: 11841091
[TBL] [Abstract][Full Text] [Related]
3. Coping with space motion sickness in Spacelab missions.
Graybiel A
Acta Astronaut; 1981; 8(9-10):1015-8. PubMed ID: 11543090
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment strategies for Space Motion Sickness.
Davis JR; Jennings RT; Beck BG
Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
[TBL] [Abstract][Full Text] [Related]
5. Relative efficacy of the proposed Space Shuttle antimotion sickness medications.
Hordinsky JR; Schwartz E; Beier J; Martin J; Aust G
Acta Astronaut; 1982; 9(6-7):375-83. PubMed ID: 11541691
[TBL] [Abstract][Full Text] [Related]
6. Why do astronauts suffer space sickness?
Oman C
New Sci; 1984 Aug; 103(1418):10-1, 13. PubMed ID: 11539311
[No Abstract] [Full Text] [Related]
7. The prevention of motion sickness in orbital flight.
Graybiel A
Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268
[TBL] [Abstract][Full Text] [Related]
8. Space motion sickness.
Homick JL
Acta Astronaut; 1979 Oct; 6(10):1259-72. PubMed ID: 11902170
[TBL] [Abstract][Full Text] [Related]
9. Comparison of treatment strategies for Space Motion Sickness.
Davis JR; Jennings RT; Beck BG
Acta Astronaut; 1993 Aug; 29(8):587-91. PubMed ID: 11541638
[TBL] [Abstract][Full Text] [Related]
10. Regulation of body fluid volume and electrolyte concentrations in spaceflight.
Smith SM; Krauhs JM; Leach CS
Adv Space Biol Med; 1997; 6():123-65. PubMed ID: 9048137
[TBL] [Abstract][Full Text] [Related]
11. Spacelab experiments on space motion sickness.
Oman CM
Acta Astronaut; 1987; 15(1):55-66. PubMed ID: 11538841
[TBL] [Abstract][Full Text] [Related]
12. Endocrine responses in long-duration manned space flight.
Leach CS; Rambaut PC
Acta Astronaut; 1975; 2(1-2):115-27. PubMed ID: 11841088
[TBL] [Abstract][Full Text] [Related]
13. Modafinil as a potential motion sickness countermeasure.
Hoyt RE; Lawson BD; McGee HA; Strompolis ML; McClellan MA
Aviat Space Environ Med; 2009 Aug; 80(8):709-15. PubMed ID: 19653573
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
Dornhoffer J; Chelonis JJ; Blake D
Otol Neurotol; 2004 Sep; 25(5):740-5. PubMed ID: 15354005
[TBL] [Abstract][Full Text] [Related]
15. Effects of drug countermeasures for space motion sickness on working memory in humans.
Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL
Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046
[TBL] [Abstract][Full Text] [Related]
16. Changes of hormones regulating electrolyte metabolism after space flight and hypokinesia.
Macho L; Fickova M; Lichardus B; Kvetnansky R; Carrey RM; Grigoriev A; Popova IA; Tigranian RA; Noskov VB
Acta Astronaut; 1992 Jul; 27():51-4. PubMed ID: 11537597
[TBL] [Abstract][Full Text] [Related]
17. A rationale for space motion sickness.
Thornton WE
Aviat Space Environ Med; 2011 Apr; 82(4):467-8. PubMed ID: 21485406
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and endocrine studies: the second manned Skylab mission.
Leach CS; Johnson PC; Rambaut PC
Aviat Space Environ Med; 1976 Apr; 47(4):402-10. PubMed ID: 179519
[TBL] [Abstract][Full Text] [Related]
19. Fluid control mechanisms in weightlessness.
Leach CS
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A74-9. PubMed ID: 3675509
[TBL] [Abstract][Full Text] [Related]
20. [Comparison between two anti-motion sickness drugs].
Wang J; Qian JK; Wang BZ; Gao JY; Shi HZ
Space Med Med Eng (Beijing); 1999 Apr; 12(2):138-40. PubMed ID: 12430546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
